Home > Income Statement > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Revenue

    Back to Income Statement
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for SYNCOM FORMULATIONS (INDIA)
Please provide your vote to see the results

SYNCOM FORMULATIONS (INDIA) Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Net Sales ₹263 Cr₹224 Cr₹220 Cr₹18,482,242 Cr₹184 Cr

What is the latest Revenue of SYNCOM FORMULATIONS (INDIA) ?

The latest Revenue ratio of SYNCOM FORMULATIONS (INDIA) is ₹263 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹263 Cr
Mar2024₹224 Cr
Mar2023₹220 Cr
Mar2022₹18,482,242 Cr
Mar2017₹184 Cr

How is Revenue of SYNCOM FORMULATIONS (INDIA) Trending?

Years Revenue % Change
Mar2025 ₹263 Cr
17.45
Mar2024 ₹224 Cr
2.09
Mar2023 ₹220 Cr
-100.00
Mar2022 ₹18,482,242 Cr
10,050,222.98
Mar2017 ₹184 Cr -

Compare Revenue of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,356.4 Cr -0.6% -8.2% -27.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,494.0 Cr -1.5% -4.8% -4.2% Stock Analytics
DIVIS LABORATORIES ₹170,514.0 Cr -0.9% -1.4% 11.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹129,044.0 Cr 0.3% 1.6% 12.1% Stock Analytics
CIPLA ₹121,574.0 Cr -0.8% -1.2% 1.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,919.0 Cr -0.8% 1.7% -5.6% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

-0.6%

-8.2%

-27.1%

SENSEX

0.7%

0.5%

9%


You may also like the below Video Courses